SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-143111
Filing Date
2017-04-27
Accepted
2017-04-27 16:31:07
Documents
4
Period of Report
2017-06-07
Effectiveness Date
2017-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d390283ddef14a.htm DEF 14A 660476
2 GRAPHIC g390283g92t85.jpg GRAPHIC 66351
3 GRAPHIC g390283snap0002.jpg GRAPHIC 1688
4 GRAPHIC g390283snap0003.jpg GRAPHIC 1591
  Complete submission text file 0001193125-17-143111.txt   758172
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 17789546
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10